Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy Pointon

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Annual Review of Pharmacology and Toxicology|October 15, 2017
Application of Microphysiological Systems to Enhance Safety Assessment in Drug DiscoveryLorna Ewart, Eva-Maria Dehne, Kristin Fabre, et al.
Scientific Reports|July 5, 2019
On the potential of in vitro organ-chip models to define temporal pharmacokinetic-pharmacodynamic relationshipsChristopher W McAleer, Amy Pointon, Christopher J Long, et al.
Computational Toxicology (Amsterdam, Netherlands)|June 20, 2022
<i>In silico</i> approaches in organ toxicity hazard assessment: Current status and future needs for predicting heart, kidney and lung toxicitiesArianna Bassan, Vinicius M Alves, Alexander Amberg, et al.
Clinical Pharmacology and Therapeutics|September 1, 2020
Time for a Fully Integrated Nonclinical-Clinical Risk Assessment to Streamline QT Prolongation Liability Determinations: A Pharma Industry PerspectiveHugo M Vargas, Michael G Rolf, Todd A Wisialowski, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Annual Review of Pharmacology and Toxicology|October 15, 2017
Application of Microphysiological Systems to Enhance Safety Assessment in Drug DiscoveryLorna Ewart, Eva-Maria Dehne, Kristin Fabre, et al.
Scientific Reports|July 5, 2019
On the potential of in vitro organ-chip models to define temporal pharmacokinetic-pharmacodynamic relationshipsChristopher W McAleer, Amy Pointon, Christopher J Long, et al.
Computational Toxicology (Amsterdam, Netherlands)|June 20, 2022
<i>In silico</i> approaches in organ toxicity hazard assessment: Current status and future needs for predicting heart, kidney and lung toxicitiesArianna Bassan, Vinicius M Alves, Alexander Amberg, et al.
Clinical Pharmacology and Therapeutics|September 1, 2020
Time for a Fully Integrated Nonclinical-Clinical Risk Assessment to Streamline QT Prolongation Liability Determinations: A Pharma Industry PerspectiveHugo M Vargas, Michael G Rolf, Todd A Wisialowski, et al.
Pageof 4